Endocrine Archives - Oncology Central Oncology Central

Find out more about the latest developments in cancer therapeutics and diagnostics in this #cancerresearch spotlight created by @MyBioTechniques : https://t.co/DMEcCFKqjk

View all

Jobs

Connecting talent with opportunity. View our featured jobs

View all

NCRI 2019: Deaths from liver cancer reach new high in England

A peek behind the paper – Kate Lines on epigenetic dysregulation in pituitary tumors

AACR19: ipilimumab, nivolumab combination demonstrates efficacy in high-grade neuroendocrine carcinoma

Serotonin levels and 1-year mortality in patients with neuroendocrine tumors: a systematic review and meta-analysis

The safety and efficacy of lenvatinib in advanced thyroid cancer patients: a Phase II trial

NICE recommends new first-line treatment Lenvima against advanced liver cancer

NCRI 2018: HiLo trial suggests low risk thyroid cancer patients can receive lower doses of radiation

Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Blood test could detect kidney cancer up to 5 years earlier

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

FDA approves first-in-class treatment for rare adrenal tumors

Born to be bad: researchers identify the genetic roots of ‘killer’ kidney cancers

Cyramza® meets primary endpoint of overall survival in liver cancer study

Advancing treatment options for medullary thyroid cancer: an interview with Jonathan Wadsley

Endogenous virus expression could help predict RCC responsiveness to immune checkpoint therapy

Phase III CELESTIAL trial of cabozantinib demonstrates significant overall survival benefit in HCC patients

Thyroid cancer in adolescents and young adults

ESMO WCGI: Promising initial results reported for immunotherapy for HCC

Sonogram scoring system developed for thyroid nodules to reduce biopsy rates

Low survival rates observed for specific thyroid cancers following bone metastasis

Signaling pathways in medullary thyroid carcinoma: therapeutic implications

Advances in diagnosis and management of familial pituitary adenomas

Resection of primary gastroenteropancreatic neuroendocrine tumors in the presence of irresectable liver metastases

Durable response to lenvatinib in progressive, therapy-refractory, metastatic paraganglioma

Login

Endocrine

Must read